Addyi (flibanserin) 100 mg tablets

Addyi is a prescription tablet containing flibanserin, used for certain cases of low sexual desire in premenopausal women. This page summarizes what it is, how it’s typically taken, and key safety points to review with a clinician. It also explains practical access topics, including Addyi price considerations for cash-pay options without insurance and US shipping from Canada.

What Addyi Is and How It Works: Addyi price

Addyi (flibanserin) is a centrally acting medicine approved for acquired, generalized hypoactive sexual desire disorder (persistently low sexual desire) in premenopausal women. Unlike drugs that work on genital blood flow, this treatment works in the brain. Its exact clinical effect is not fully understood, but it is known to act on serotonin receptors (as a 5-HT1A agonist and 5-HT2A antagonist) and may influence dopamine and norepinephrine signaling, which are involved in sexual desire and arousal.

Low desire can have many contributors, including mood symptoms, sleep disruption, chronic illness, relationship stressors, and medication effects. A prescriber generally rules out other causes before starting therapy. Addyi is sometimes described in the media as “female Viagra,” but that nickname can be misleading because the mechanisms and approved uses differ.

Prescription details may be confirmed with the original prescriber when required.

Who It’s For

This medicine is indicated for premenopausal women with acquired (developed after a period of typical desire) and generalized (not limited to certain partners or situations) HSDD. It is not intended for reduced desire that is primarily due to another medical condition, a psychiatric condition, problems within a relationship, or the effects of other medicines or substances. Background reading on the condition is available in the Hypoactive Sexual Desire Disorder hub, and related products can be browsed in Womens Health.

Important “not for” situations are commonly listed on the label and Medication Guide. These include use in men and use in postmenopausal women. Addyi also has key restrictions in people with certain liver problems and in those taking some interacting medications that can raise flibanserin exposure. If pregnancy is possible, a clinician may discuss pregnancy planning and symptom contributors; for broader context on women’s health topics, the Womens Health Articles collection can be a helpful starting point.

Dosage and Usage

Addyi is supplied as an oral tablet and is typically taken once daily at bedtime, which helps reduce the impact of common central nervous system effects such as sleepiness or dizziness. Directions can differ based on the prescriber’s judgment and the current label, so the pharmacy label and Medication Guide should be treated as the primary instructions. Doses should not be doubled after a missed dose; the next scheduled bedtime dose is generally the reference point clinicians use for routine adherence questions.

Some people first notice side effects before noticing any benefit, so careful follow-up matters. When discussing Addyi price alongside treatment expectations, clinicians often reference the label’s recommendation to reassess response and tolerability after a defined trial period, and to discontinue if there is no meaningful improvement. Why it matters: Tracking symptoms and side effects supports safer follow-up conversations.

Because sleep, stress, and chronic diseases can affect sexual function, clinicians may also review contributing factors. For readers who want broader background on sexual function and metabolic health, see Intimacy And Diabetes Guide and Diabetes And Sexual Health.

Strengths and Forms

Addyi is commonly supplied as flibanserin 100 mg tablets for oral use. Availability of specific packaging (such as bottle count) can vary by dispensing pharmacy and by supply conditions, but the standard labeled strength is 100 mg. If a prescriber writes for a different quantity or a different titration plan, the pharmacy label should match those instructions.

The table below summarizes the usual presentation for this product page:

Storage and Travel Basics

Store tablets at controlled room temperature and keep them in the original container unless a pharmacist advises otherwise. Protect the medicine from excess heat and moisture, and keep it out of reach of children and pets. Do not use tablets beyond the printed expiration date, and do not transfer them into an unmarked container that could lead to identification errors.

For travel, bring enough doses for the trip and keep a copy of the prescription information. Crossing time zones can shift the usual bedtime schedule, so some people choose to confirm timing with their prescriber before travel. Quick tip: Keep an up-to-date medication list with strengths and dosing times.

Side Effects and Safety

Commonly reported side effects include sleepiness, dizziness, nausea, tiredness, dry mouth, and trouble sleeping. Because this treatment can cause sedation, activities requiring full alertness may be affected, especially if the dose is not taken at bedtime as directed. Some people also report symptoms that overlap with other conditions (such as fatigue), so clinicians may review sleep habits and general health during follow-up.

More serious risks can include hypotension (low blood pressure) and syncope (fainting), particularly when flibanserin levels rise due to certain interactions or when taken in unsafe circumstances described on the label. Mood changes have also been reported; any new or worsening depression symptoms should be discussed promptly with a healthcare professional. Orders are dispensed by licensed Canadian pharmacies after documentation review.

Because many women managing chronic conditions also experience sexual concerns, it can help to review contributing factors beyond medication. Background reading on sleep and metabolic health is available in Sleep And Diabetes Risk.

Drug Interactions and Cautions

Addyi has clinically important interactions that can increase side effects or raise the risk of low blood pressure and fainting. The best safeguard is a complete medication review that includes prescription drugs, over-the-counter products, and supplements. Interactions of concern often involve medicines that affect CYP3A4 (a key drug-metabolizing pathway) or that add to central nervous system depression.

Alcohol, sedatives, and metabolism inhibitors

Alcohol and other sedating substances can increase the risk of significant sleepiness and blood-pressure-related events. In addition, certain antibiotics, antifungals, HIV medications, and other drugs can inhibit metabolism and increase flibanserin exposure; grapefruit products may also affect metabolism for some drugs, so a pharmacist may advise caution. Conversely, some medicines can induce metabolism and reduce exposure, which may change tolerability or effectiveness. When reviewing Addyi price, it is also reasonable to ask the dispensing pharmacy whether an interaction check is performed against the submitted medication list and whether the current label warnings are included with the shipment.

If a new medication is started while taking flibanserin, a clinician or pharmacist should reassess compatibility. People with liver impairment typically require special caution because flibanserin exposure can increase. Any episode of fainting, severe dizziness, or injury after a fall should be evaluated urgently.

Compare With Alternatives

For HSDD, clinicians may consider several approaches depending on the underlying contributors. Some alternatives are non-drug strategies, such as counseling or sex therapy, addressing relationship factors, improving sleep, and adjusting other medicines that may reduce libido. In certain cases, prescribers may discuss other pharmacologic options (including injectable therapies approved for HSDD or off-label hormonal approaches), but appropriateness depends on the individual’s history and contraindications.

When comparing options, it helps to separate desire concerns from arousal or pain conditions, because the evaluation and treatments can differ. For readers looking for broader context on fertility and endocrine factors that can overlap with sexual health concerns, see Female Fertility And Diabetes and Diabetes And Fertility. For an example of another prescription tablet product page within this catalog (not an alternative to flibanserin), see Pulmicort Nebuamp.

Pricing and Access

Out-of-pocket expenses for this therapy vary based on prescription details, dispensing pharmacy fees, and whether a brand or generic option is provided where permitted. Addyi price can also differ by the quantity dispensed and by any required clinical checks related to interaction risk. If a generic flibanserin option is available through a dispensing pharmacy, the prescription must allow substitution under applicable rules.

For people comparing Addyi cost without insurance, it can help to focus on total cash-pay costs rather than only a per-tablet figure. The Promotions page may list general programs that apply to some prescriptions, but availability can change and may not apply to every medicine. The service supports cash-pay access to prescription medicines across the border.

To proceed through the platform, submit the prescription and required documentation; a referral process routes fulfillment to a licensed pharmacy partner when appropriate.

Authoritative Sources

Use these references to confirm current labeling, contraindications, and safety warnings before starting or changing therapy. Pharmacists and prescribers also rely on the official prescribing information and Medication Guide for the most current updates.

• FDA prescribing information repository for approved labels
• MedlinePlus patient information on flibanserin

For site processing and delivery selection at checkout, requests can be sent using prompt, express, cold-chain shipping when required.

This content is for informational purposes only and is not a substitute for professional medical advice.